Investment Thesis
Alignment Healthcare demonstrates strong revenue growth of 46.1% YoY and positive free cash flow generation of $113.1M, indicating operational traction in the healthcare services sector. However, near-zero net profitability (-0.0% margin), minimal operating margin (0.4%), and negative ROE/ROA suggest the company is not yet converting strong top-line growth into sustainable bottom-line earnings, requiring proof of margin expansion.
ALHC Strengths
- Strong revenue growth of 46.1% YoY demonstrates significant market demand and operational scaling
- Solid free cash flow of $113.1M with 2.9% FCF margin indicates underlying business can generate cash despite low net income
- Healthy liquidity position with current ratio of 1.71x and substantial cash reserves of $575.8M provides financial flexibility
- Positive operating cash flow of $139.9M exceeds modest capital expenditure of $26.8M, showing efficient capital deployment
ALHC Risks
- Near-zero net profitability (-0.0% net margin) despite 46.1% revenue growth indicates significant operating inefficiencies or high cost structure not scaling proportionally
- Negative return metrics (ROE -0.4%, ROA -0.1%) demonstrate shareholder value is being destroyed rather than created despite growth
- High leverage with debt/equity ratio of 1.80x combined with minimal profitability reduces margin of safety and limits financial flexibility
- Substantial insider activity with 36 Form 4 filings in 90 days warrants scrutiny for potential insider selling or unusual transactions
- Operating margin of only 0.4% on $3.9B revenue leaves minimal cushion for operational disruptions in highly regulated healthcare sector
Key Metrics to Watch
- Operating margin expansion and path to sustainable profitability - critical test of business model viability
- Year-over-year revenue growth sustainability - whether 46.1% growth can be maintained as company scales
- Free cash flow to net income conversion - assess whether company can translate cash generation into actual earnings
- Debt service coverage and leverage ratios - monitor financial stability given 1.80x debt/equity ratio
- Insider transaction patterns and volumes - continue tracking Form 4 filings for signs of confidence or concern from management
ALHC Financial Metrics
ALHC Profitability Ratios
ALHC Balance Sheet & Liquidity
ALHC 5-Year Financial Trend
5-Year Trend Summary: Alignment Healthcare, Inc.'s revenue has grown significantly by 54% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.79 indicates the company is currently unprofitable.
ALHC Growth Metrics (YoY)
ALHC Quarterly Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $692.4M | $3.7M | $0.02 |
| Q2 2025 | $681.3M | $6.6M | $0.03 |
| Q1 2025 | $628.6M | -$9.1M | $-0.05 |
| Q3 2024 | $456.7M | -$26.4M | $-0.14 |
| Q2 2024 | $462.4M | -$24.0M | $-0.13 |
| Q1 2024 | $439.2M | -$37.3M | $-0.20 |
| Q3 2023 | $360.0M | -$35.0M | $-0.19 |
| Q2 2023 | $366.2M | -$11.6M | $-0.06 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
ALHC Capital Allocation
ALHC SEC Filings
Access official SEC EDGAR filings for Alignment Healthcare, Inc. (CIK: 0001832466)